论文部分内容阅读
目的探讨颅内血肿微创穿刺清除术治疗颅内出血(ICH)的临床疗效。方法将62例ICH患者按随机数字表法分为两组,每组31例。观察组行颅内血肿微创穿刺清除术治疗,对照组行传统的开颅血肿清除术治疗,对比两组患者的治疗效果。结果两组治疗前神经功能缺损评分相比,差异未见统计学意义(P>0.05);治疗后,观察组神经功能缺损评分明显低于对照组,差异有统计学意义(P<0.05);观察组治疗后抗生素应用时间、术程及住院天数明显短于对照组,差异有统计学意义(P<0.05);观察组与对照组治疗有效率分别为90.3%、67.7%,两组对比差异有统计学意义(P<0.05);观察组与对照组并发症发生率分别为12.9%、16.1%,两组对比差异未见统计学意义(P>0.05)。结论采用颅内血肿微创穿刺清除术治疗ICH,临床疗效安全、可靠,应用价值显著,值得推广。
Objective To investigate the clinical effect of intracranial hematoma minimally invasive puncture in the treatment of intracranial hemorrhage (ICH). Methods 62 cases of ICH patients were divided into two groups according to random number table method, each group of 31 cases. The observation group was treated with minimally invasive puncture of intracranial hematoma, while the control group was treated with conventional craniotomy. The therapeutic effect was compared between the two groups. Results There was no significant difference in neurological deficit score between the two groups before treatment (P> 0.05). After treatment, the score of neurological deficit in the observation group was significantly lower than that of the control group (P <0.05). The observation group treated with antibiotics after treatment time, duration of surgery and hospitalization was significantly shorter than the control group, the difference was statistically significant (P <0.05); observation group and control group, the effective rates were 90.3%, 67.7%, the difference between the two groups (P <0.05). The complication rates of the observation group and the control group were 12.9% and 16.1% respectively, with no significant difference between the two groups (P> 0.05). Conclusion Intracranial hematoma minimally invasive surgery for the treatment of ICH, the clinical efficacy of safe, reliable, significant value, it is worth promoting.